Cargando…

Immunomodulatory Drugs Alter the Metabolism and the Extracellular Release of Soluble Mediators by Normal Monocytes

Immunomodulatory drugs (IMiDs) are used in the treatment of hematological malignancies, especially multiple myeloma. IMiDs have direct anticancer effects but also indirect effects via cancer-supporting stromal cells. Monocytes are a stromal cell subset whose metabolism is modulated by the microenvir...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rundgren, Ida Marie, Ryningen, Anita, Anderson Tvedt, Tor Henrik, Bruserud, Øystein, Ersvær, Elisabeth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7024334/ https://www.ncbi.nlm.nih.gov/pubmed/31963193 http://dx.doi.org/10.3390/molecules25020367

Ejemplares similares

A Pilot Study of Circulating Monocyte Subsets in Patients Treated with Stem Cell Transplantation for High-Risk Hematological Malignancies
por: Rundgren, Ida Marie, et al.
Publicado: (2020)

Circulating monocyte subsets in multiple myeloma patients receiving autologous stem cell transplantation – a study of the preconditioning status and the course until posttransplant reconstitution for a consecutive group of patients
por: Rundgren, Ida Marie, et al.
Publicado: (2019)

Interleukin-6 in Allogeneic Stem Cell Transplantation: Its Possible Importance for Immunoregulation and As a Therapeutic Target
por: Tvedt, Tor Henrik Anderson, et al.
Publicado: (2017)

Cytokine Release Syndrome in the Immunotherapy of Hematological Malignancies: The Biology behind and Possible Clinical Consequences
por: Tvedt, Tor Henrik Anderson, et al.
Publicado: (2021)

IL-6 Responsiveness of CD4(+) and CD8(+) T Cells after Allogeneic Stem Cell Transplantation Differs between Patients and Is Associated with Previous Acute Graft versus Host Disease and Pretransplant Antithymocyte Globulin Therapy
por: Tvedt, Tor Henrik Anderson, et al.
Publicado: (2022)

The Constitutive Extracellular Protein Release by Acute Myeloid Leukemia Cells—A Proteomic Study of Patient Heterogeneity and Its Modulation by Mesenchymal Stromal Cells
por: Aasebø, Elise, et al.
Publicado: (2021)

Combined C-Reactive Protein and Novel Inflammatory Parameters as a Predictor in Cancer—What Can We Learn from the Hematological Experience?
por: Bruserud, Øystein, et al.
Publicado: (2020)

Combination of Intensive Chemotherapy and Anticancer Vaccines in the Treatment of Human Malignancies: The Hematological Experience
por: Liseth, Knut, et al.
Publicado: (2010)

The Complexity of Targeting PI3K-Akt-mTOR Signalling in Human Acute Myeloid Leukaemia: The Importance of Leukemic Cell Heterogeneity, Neighbouring Mesenchymal Stem Cells and Immunocompetent Cells
por: Brenner, Annette K., et al.
Publicado: (2016)

Clonal Heterogeneity Reflected by PI3K-AKT-mTOR Signaling in Human Acute Myeloid Leukemia Cells and Its Association with Adverse Prognosis
por: Nepstad, Ina, et al.
Publicado: (2018)

Therapeutic Use of Valproic Acid and All-Trans Retinoic Acid in Acute Myeloid Leukemia—Literature Review and Discussion of Possible Use in Relapse after Allogeneic Stem Cell Transplantation
por: Bruserud, Øystein, et al.
Publicado: (2021)

Preconditioning Serum Levels of Endothelial Cell-Derived Molecules and the Risk of Posttransplant Complications in Patients Treated with Allogeneic Stem Cell Transplantation
por: Lindås, Roald, et al.
Publicado: (2014)

Inhibition of Mammalian Target of Rapamycin in Human Acute Myeloid Leukemia Cells Has Diverse Effects That Depend on the Environmental In Vitro Stress
por: Ryningen, Anita, et al.
Publicado: (2012)

Targeting Cellular Metabolism in Acute Myeloid Leukemia and the Role of Patient Heterogeneity
por: Grønningsæter, Ida Sofie, et al.
Publicado: (2020)

Immunological Heterogeneity of Healthy Peripheral Blood Stem Cell Donors—Effects of Granulocyte Colony-Stimulating Factor on Inflammatory Responses
por: Tvedt, Tor Henrik Anderson, et al.
Publicado: (2018)

Future Perspectives: Therapeutic Targeting of Notch Signalling May Become a Strategy in Patients Receiving Stem Cell Transplantation for Hematologic Malignancies
por: Ersvaer, Elisabeth, et al.
Publicado: (2011)

The Acute Phase Reaction and Its Prognostic Impact in Patients with Head and Neck Squamous Cell Carcinoma: Single Biomarkers Including C-Reactive Protein Versus Biomarker Profiles
por: Aarstad, Helene Hersvik, et al.
Publicado: (2020)

The Biological Context of C-Reactive Protein as a Prognostic Marker in Renal Cell Carcinoma: Studies on the Acute Phase Cytokine Profile
por: Aarstad, Helene Hersvik, et al.
Publicado: (2020)

Necrotizing Bacterial Myositis as the Initial Presentation of Severe Aplastic Anaemia
por: Rørvik, Synne Dragesund, et al.
Publicado: (2021)

Connexin expression in human acute myeloid leukemia cells: Identification of patient subsets based on protein and global gene expression profiles
por: REIKVAM, HÅKON, et al.
Publicado: (2015)

Intensive chemotherapy for acute myeloid leukemia differentially affects circulating T(C)1, T(H)1, T(H)17 and T(REG )cells
por: Ersvaer, Elisabeth, et al.
Publicado: (2010)

Effects of cytarabine on activation of human T cells – cytarabine has concentration-dependent effects that are modulated both by valproic acid and all-trans retinoic acid
por: Ersvaer, Elisabeth, et al.
Publicado: (2015)

Immunomodulation Induced by Stem Cell Mobilization and Harvesting in Healthy Donors: Increased Systemic Osteopontin Levels after Treatment with Granulocyte Colony-Stimulating Factor
por: Melve, Guro Kristin, et al.
Publicado: (2016)

Serum levels of the IL-6 family of cytokines predict prognosis in renal cell carcinoma (RCC)
por: Gudbrandsdottir, Gigja, et al.
Publicado: (2020)

Peripheral Blood Stem Cell Mobilization in Healthy Donors by Granulocyte Colony-Stimulating Factor Causes Preferential Mobilization of Lymphocyte Subsets
por: Melve, Guro Kristin, et al.
Publicado: (2018)

Effects of the Autophagy-Inhibiting Agent Chloroquine on Acute Myeloid Leukemia Cells; Characterization of Patient Heterogeneity
por: Grønningsæter, Ida Sofie, et al.
Publicado: (2021)

The combination of valproic acid, all-trans retinoic acid and low-dose cytarabine as disease-stabilizing treatment in acute myeloid leukemia
por: Fredly, Hanne, et al.
Publicado: (2013)

Spontaneous Splenic Artery Rupture as the First Symptom of Systemic Amyloidosis
por: Bruserud, Øyvind, et al.
Publicado: (2021)

Pretransplant Levels of CRP and Interleukin-6 Family Cytokines; Effects on Outcome after Allogeneic Stem Cell Transplantation
por: Tvedt, Tor Henrik, et al.
Publicado: (2016)

p53 Protein Isoform Profiles in AML: Correlation with Distinct Differentiation Stages and Response to Epigenetic Differentiation Therapy
por: Haaland, Ingvild, et al.
Publicado: (2021)

Depletion of soluble cytokines unlocks the immunomodulatory bioactivity of extracellular vesicles
por: Roux, Quentin, et al.
Publicado: (2023)

Proteomic Profiling of Primary Human Acute Myeloid Leukemia Cells Does Not Reflect Their Constitutive Release of Soluble Mediators
por: Aasebø, Elise, et al.
Publicado: (2018)

The Protein Kinase C Agonist PEP005 (Ingenol 3-Angelate) in the Treatment of Human Cancer: A Balance between Efficacy and Toxicity
por: Ersvaer, Elisabeth, et al.
Publicado: (2010)

Power Production and Biochemical Markers of Metabolic Stress and Muscle Damage Following a Single Bout of Short-Sprint and Heavy Strength Exercise in Well-Trained Cyclists
por: Kristoffersen, Morten, et al.
Publicado: (2018)

The Extracellular Bone Marrow Microenvironment—A Proteomic Comparison of Constitutive Protein Release by In Vitro Cultured Osteoblasts and Mesenchymal Stem Cells
por: Aasebø, Elise, et al.
Publicado: (2020)

Novel insights into the treatment of complement-mediated hemolytic anemias
por: Berentsen, Sigbjørn, et al.
Publicado: (2019)

Systemic levels of the endothelium-derived soluble adhesion molecules endocan and E-selectin in patients with suspected deep vein thrombosis
por: Mosevoll, Knut Anders, et al.
Publicado: (2014)

Patient Heterogeneity in Acute Myeloid Leukemia: Leukemic Cell Communication by Release of Soluble Mediators and Its Effects on Mesenchymal Stem Cells
por: Aasebø, Elise, et al.
Publicado: (2021)

Vacuolar ATPase Is a Possible Therapeutic Target in Acute Myeloid Leukemia: Focus on Patient Heterogeneity and Treatment Toxicity
por: Bartaula-Brevik, Sushma, et al.
Publicado: (2023)

Up-regulation of anti-apoptotic genes confers resistance to the novel anti-leukaemic compound PEP005 in primary AML cells
por: Hampson, Peter, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_mi8ck0bq72mgf0dpv3c77ub1kr